Dr. Melissa E. Middeldorp earned her PhD in 2019 from the University of Adelaide, where her thesis explored risk factors, disease progression, and sex-based differences in AF patients. In 2022, Dr. Middeldorp completed a Master of Public Health at Harvard University, enhancing her expertise in epidemiology and public health. She subsequently undertook a postdoctoral fellowship at Cedars-Sinai Medical Center in Los Angeles, focusing on AF epidemiology, and is currently affiliated with the University Medical Center Groningen in the Netherlands.
Dr. Middeldorp has contributed to numerous peer-reviewed publications, serves on several committees and regularly speaks overseas at major international conferences, including studies on the impact of lifestyle modifications on AF management, sex differences and AF, and the role of education and digital health in medicine. She is also involved in supervising postgraduate students and continues to contribute to the advancement of cardiovascular research and patient care strategies.